tiprankstipranks
Lisata Therapeutics (DE:8NE)
FRANKFURT:8NE

Lisata Therapeutics (8NE) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
3Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Lisata Therapeutics’s (8NE) Moving Averages Convergence Divergence (MACD) indicator is 0.08, suggesting Lisata Therapeutics is a Sell.
Lisata Therapeutics’s (8NE) 20-Day exponential moving average is 2.62, while Lisata Therapeutics’s (8NE) share price is €2.9, making it a Buy.
Lisata Therapeutics’s (8NE) 50-Day exponential moving average is 2.51, while Lisata Therapeutics’s (8NE) share price is €2.9, making it a Buy.

Lisata Therapeutics (8NE) Pivot Points

Mar 01, 2024, 07:03 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.70
2.70
2.70
2.70
2.70
2.70
2.70
Fibonacci
2.70
2.70
2.70
2.70
2.70
2.70
2.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lisata Therapeutics (8NE) Moving Averages

Mar 01, 2024, 07:03 AM
Period
Simple
Exponential
MA5
2.71Buy
2.75Buy
MA10
2.69Buy
2.69Buy
MA20
2.55Buy
2.62Buy
MA50
2.55Buy
2.51Buy
MA100
2.30Buy
2.44Buy
MA200
2.56Buy
2.61Buy
Lisata Therapeutics’s (8NE) 10-Day exponential moving average is 2.69, while Lisata Therapeutics’s (8NE) share price is €2.9, making it a Buy.
Lisata Therapeutics’s (8NE) 100-Day exponential moving average is 2.44, while Lisata Therapeutics’s (8NE) share price is €2.9, making it a Buy.
Lisata Therapeutics’s (8NE) stock price is €2.9 and Lisata Therapeutics’s (8NE) 50-day simple moving average is 2.55, creating a Buy signal.
Lisata Therapeutics’s (8NE) stock price is €2.9 and Lisata Therapeutics’s (8NE) 100-day simple moving average is 2.30, creating a Buy signal.
Lisata Therapeutics’s (8NE) stock price is €2.9 and Lisata Therapeutics’s (8NE) 200-day simple moving average is 2.56, creating a Buy signal.

Lisata Therapeutics (8NE) Technical Indicators

Mar 01, 2024, 07:03 AM
Name
Value
Implied Action
RSI (14)
63.02
Neutral
STOCH (9,6)
78.33
Neutral
STOCHRSI (14)
81.94
Sell
MACD (12,26)
0.08
Sell
ADX (14)
11.02
Buy
Williams %R
0.00
-
CCI (14)
151.44
Sell
ATR (14)
0.09
-
Ultimate Oscillator
60.14
Neutral
ROC
21.85
Buy
Lisata Therapeutics’s (8NE) Relative Strength Index (RSI) is 63.02, creating a Neutral signal.
Lisata Therapeutics’s (8NE) Trend Strength Indicator (ADX) is 11.02, creating a Buy signal.
Lisata Therapeutics’s (8NE) Commodity Channel Index (CCI) is 151.44, creating a Sell signal.
Lisata Therapeutics’s (8NE) Price Rate of Change (ROC) is 21.85, creating a Buy signal.

FAQ

Is 8NE a Buy, Hold, or Sell?
Based on 8NE’s technical indicators, 8NE is a Strong Buy.
    What is 8NE’s RSI (14)?
    8NE’s RSI (14) is 63.02, which suggests 8NE is a Neutral.
      What is 8NE’s MACD?
      8NE’s MACD is 0.08, which suggests 8NE is a Sell.
        What is 8NE’s 5-day moving average?
        8NE’s 5-day moving average is 2.71, which suggests 8NE is a Buy.
          What is 8NE’s 20-day moving average?
          8NE 20-day moving average is 2.55, which suggests 8NE is a Buy.
            What is 8NE’s 50-day moving average?
            8NE’s 50-day moving average is 2.55, which suggests 8NE is a Buy.
              What is 8NE’s 200-day moving average?
              8NE’s 200-day moving average is 2.56, which suggests 8NE is a Buy.
                What is 8NE’s Williams % R (14)?
                Currently, no data Available
                What is 8NE’s CCI (14)?
                8NE’s CCI (14) is 151.44, which suggests 8NE is a Sell.
                  What is the share price of Lisata Therapeutics?
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis